Cleared Traditional

K191870 - VV330 Continuous ECG Platform, VivaLNK Adhesive Patch

K191870 is an FDA 510(k) clearance for VV330 Continuous ECG Platform, manufactured by VivaLNK, Inc.. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 179-day FDA review.

K191870 · VivaLNK, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
179d
Days
Class 2
Risk

K191870 is an FDA 510(k) clearance for the VV330 Continuous ECG Platform, VivaLNK Adhesive Patch. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by VivaLNK, Inc. (Campbell, US). The FDA issued a Cleared decision on January 7, 2020 after a review of 179 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all VivaLNK, Inc. devices

FDA 510(k) Submission Details - K191870

510(k) Number K191870 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2019
Decision Date January 07, 2020
Days to Decision 179 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d slower than avg
Panel avg: 125d · This submission: 179d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 134
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K191870.
Vista Solution Monitoring Kit, Vista Solution 2 10-day Evaluation Kit, VistaTablet 2 (Boxed)
K193343 · Vitalconnect, Inc. · Apr 2020
Philips Biosensor BX100
K192875 · Philips Medical Systems · Apr 2020
VitalPatch 5D Biosensor - single, VitalPatch 7D Biosensor - single, VitalPatch 5D Biosensor – bag of 20, VitalPatch 7D Biosensor – bag of 20
K192757 · Vitalconnect, Inc. · Feb 2020
BioSticker System
K191614 · Biointellisense, Inc. · Dec 2019
Life Sensor Cardiac Monitor
K191331 · Braveheart Wireless, Inc. · Jun 2019
VitalPatch 7D Biosensor - single, VitalPatch 7D Biosensor - bag of 20
K190916 · Vitalconnect, Inc. · Jun 2019